Evidence map›Paper›PMID 36101692›Full record

ArticlePublic health in practice (Oxford, England)2020

Drug shortage crisis in Sudan in times of COVID-19.

Don Eliseo Lucero-Prisno, Yasir Ahmed Mohammed Elhadi, Mohamed AbdulKareem Adam Modber, Mohamed Babiker Musa, Salma Elmukashfi Eltahir Mohammed, Khlood Fathi Hassan, Alaa Dafallah, Xu Lin, Attaullah Ahmadi, Sylvester Adeyemi and 2 more

Abstract read
In one paragraph

Article in Public health in practice (Oxford, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Vietnam's success story against COVID-19.Public health in practice (Oxford, England) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Don Eliseo Lucero-PrisnoDepartment of Global Health and Development, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Yasir Ahmed Mohammed ElhadiHigh Institute of Public Health, Department of Health Administration and Behavioral Sciences, Alexandria University, Alexandria, Egypt.
Mohamed AbdulKareem Adam ModberGlobal Health Focus Africa, Khartoum, Sudan.
Mohamed Babiker MusaGlobal Health Focus Africa, Khartoum, Sudan.
Salma Elmukashfi Eltahir MohammedGlobal Health Focus Africa, Khartoum, Sudan.
Khlood Fathi HassanGlobal Health Focus Africa, Khartoum, Sudan.
Alaa DafallahGlobal Health Focus Africa, Khartoum, Sudan.
Xu LinDepartment of Thoracic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, PR China.
Attaullah AhmadiMedical Research Center, Kateb University, Kabul, Afghanistan.
Sylvester AdeyemiGlobal Health Focus Africa, Abuja, Nigeria.
Aniekan EkpenyongGlobal Health Focus Africa, Abuja, Nigeria.
Yusuff Adebayo AdebisiFaculty of Pharmacy, University of Ibadan, Ibadan, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sudan is witnessing severe drugs, medicines, and medical supplies shortages, which present a major impediment to the provision of emergency healthcare services. Drug insecurity in Sudan is as a result of several accumulated factors, primarily due to worsening economic condition, inappropriate pricing policy, privatization of the pharmaceutical sector, poor manufacturing and weak weak weregulatory system. These could threaten patient health through replacement of highly efficacious medicines with less effective alternatives and by impacting the scheduling of urgent medical operations and procedures. Drug and medicine shortages are of catastrophic impact especially amid the current epidemic of COVID-19 where these are salient needs. Efforts should be quickly directed to ensure immediate access to pharmaceutical products and other essential health commodities. Effective policies on drug importation, production, pricing, and distribution should be established to avoid the consequences of an impending crisis.

Indexed as

AfricaCOVID-19Drug shortagemedical supplies shortagemedicine insecuritySudan

Identifiers

PMID36101692
PMCPMC9461216

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.